Research output per year
Research output per year
Fingerprint
Dive into the research topics where Steve Schoonooghe is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Q586B2 is a crucial virulence factor during the early stages of Trypanosoma brucei infection that is conserved amongst trypanosomatids
Stijlemans, B., De Baetselier, P., Van Molle, I., Lecordier, L., Hendrickx, E., Romão, E., Vincke, C., Baetens, W., Schoonooghe, S., Hassanzadeh-Ghassabeh, G., Korf, H., Wallays, M., Pinto Torres, J. E., Perez-Morga, D., Brys, L., Campetella, O., Leguizamón, M. S., Claes, M., Hendrickx, S., Mabille, D. & 6 others, , 27 Feb 2024, In: Nature Communications. 15, 1, p. 1779 16 p., 1779.Research output: Contribution to journal › Article › peer-review
Open Access -
Development and Characterization of Nanobodies Targeting the Kupffer Cell
Zheng, F., Zhou, J., Ouyang, Z., Zhang, J., Wang, X., Muyldermans, S., Van Ginderachter, J., Devoogdt, N., Wen, Y., Schoonooghe, S. & Raes, G., 22 Feb 2021, In: Frontiers in Immunology. 12, 12 p., 641819.Research output: Contribution to journal › Article › peer-review
Open AccessFile7 Citations (Scopus)67 Downloads (Pure) -
Development of Neutralizing Multimeric Nanobody Constructs Directed against IL-13: From Immunization to Lead Optimization
Gevenois, P. J-L. Y., De Pauw, P., Schoonooghe, S., Delporte, C., Sebti, T., Amighi, K., Muyldermans, S. & Wauthoz, N., 15 Nov 2021, In: Journal of Immunology. 207, 10, p. 2608-2620 13 p.Research output: Contribution to journal › Article › peer-review
Open Access5 Citations (Scopus) -
Anti-macrophage mannose receptor single variable domains for use in cardiovascular diseases
De Baetselier, P., Raes, G., Schoonooghe, S., De Vos, J., Lahoutte, T., Devoogdt, N., Hernot, S., Bala, G. & Tierens, S., 30 Jan 2019, IPC No. A61K39/00, C07K16/28, EPO, Patent No. EP2968487B, 17 Mar 2014, Priority date 15 Mar 2013, Priority No. US61/798071Research output: Patent
-
Evaluating a Single Domain Antibody Targeting Human PD-L1 as a Nuclear Imaging and Therapeutic Agent
Broos, K., Lecocq, Q., Xavier, C., Bridoux, J., Nguyen, T., Corthals, J., Schoonooghe, S., Lion, E., Raes, G., Keyaerts, M., Devoogdt, N. & Breckpot, K., 21 Jun 2019, In: Cancers. 11, 6, 19 p., 872.Research output: Contribution to journal › Article › peer-review
Open Access55 Citations (Scopus)
Activities
- 2 Talk or presentation at a conference
-
Noninvasive imaging and inhibition of human programmed death ligand 1 (PD-L1) using nanobody K2 to improve cancer immunotherapy
Robin Maximilian Awad (Contributor), Dora Mugoli Chigoho (Contributor), Katrijn Broos (Contributor), Quentin Lecocq (Contributor), Katty Zeven (Contributor), Thomas Ertveldt (Contributor), Lien De Beck (Contributor), Hannelore Ceuppens (Contributor), Yannick De Vlaeminck (Contributor), Cleo Goyvaerts (Contributor), Steve Schoonooghe (Contributor), Vicky Caveliers (Contributor), Catarina Xavier (Contributor), Jessica Bridoux (Contributor), Geert Raes (Contributor), Marleen Keyaerts (Contributor), Nick Devoogdt (Contributor) & Karine Breckpot (Speaker)
25 Oct 2021 → 26 Oct 2021Activity: Talk or presentation › Talk or presentation at a conference
File -
Specificity evaluation and disease monitoring in arthritis imaging with complement receptor of the Ig superfamily targeting nanobodies
Fang Zheng (Speaker), Tony Lahoutte (Contributor), Serge Muyldermans (Contributor), Patrick De Baetselier (Contributor), Steve Schoonooghe (Contributor), Nick Devoogdt (Contributor) & Geert Raes (Contributor)
13 Sep 2017 → 16 Sep 2017Activity: Talk or presentation › Talk or presentation at a conference